Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.

Hashimoto D, Arima K, Nakagawa S, Negoro Y, Hirata T, Hirota M, Inomata M, Fukuzawa K, Ohga T, Saeki H, Oki E, Yamashita YI, Chikamoto A, Baba H, Maehara Y.

J Gastroenterol. 2019 May;54(5):437-448. doi: 10.1007/s00535-018-01535-9. Epub 2018 Dec 4.

PMID:
30515563
2.

A  case  of  adenoid  cystic  carcinoma  of  the  breast.

Nozoe T, Nozoe E, Ohga T, Ezaki T, Sueishi K.

J Med Invest. 2018;65(3.4):289-291. doi: 10.2152/jmi.65.289.

3.

Definition of Prognosis Based on Lymph Node Metastasis and Elevation of Serum C-Reactive Protein for Patients with Gastric Carcinoma Treated with Curative Resection.

Nozoe T, Kono M, Hashimoto N, Tsujita E, Kuma S, Ohga T.

J Med Invest. 2018;65(3.4):191-194. doi: 10.2152/jmi.65.191.

4.

Acute limb ischemia of the lower extremity associated with left upper lobe surgery for primary lung cancer.

Inoue S, Kuma S, Ohga T, Tokuishi K, Okabayashi K.

J Vasc Surg Cases Innov Tech. 2018 Apr 14;4(2):83-86. doi: 10.1016/j.jvscit.2017.12.013. eCollection 2018 Jun.

5.

Superficial temporal artery aneurysm associated with immunoglobulin G4-related disease.

Kuma S, Takeshima T, Ohga T, Nozoe T, Sueishi K.

J Vasc Surg Cases Innov Tech. 2017 Dec 18;3(4):243-246. doi: 10.1016/j.jvscit.2017.10.005. eCollection 2017 Dec.

6.
7.

Rerupture of nonparasitic liver cyst treated with cyst fenestration: a case report.

Inoue K, Iguchi T, Ito S, Ohga T, Nozoe T, Shirabe K, Ezaki T, Maehara Y.

Surg Case Rep. 2015;1(1):71. doi: 10.1186/s40792-015-0075-8. Epub 2015 Sep 2.

8.

Definitive chemoradiotherapy and salvage esophagectomy for esophageal cancer associated with multiple lung metastases: a case report.

Fujinaka Y, Morita M, Ohga T, Kakeji Y, Yano T, Maehara Y.

Int Surg. 2014 Sep-Oct;99(5):640-4. doi: 10.9738/INTSURG-D-13-00123.1.

9.

Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.

Nozoe T, Matono R, Ijichi H, Ohga T, Ezaki T.

Int Surg. 2014 Sep-Oct;99(5):512-7. doi: 10.9738/INTSURG-D-13-00118.1.

10.

Esophagectomy-related thoracic duct injury detected by lymphoscintigraphy with 99mTc-diethylenetriamine pentaacetic acid-human serum albumin: report of a case.

Tsuda Y, Morita M, Saeki H, Ando K, Ida S, Kimura Y, Oki E, Ohga T, Kusumoto T, Abe K, Baba S, Isoda T, Maehara Y.

Surg Today. 2015 Apr;45(4):517-21. doi: 10.1007/s00595-014-0968-3. Epub 2014 Aug 1.

PMID:
25080863
11.

Impact of high preoperative steroid doses on postoperative complications among patients on prolonged preoperative steroid therapy.

Iguchi T, Shirabe K, Inoue K, Ito S, Ohga T, Nozoe T, Ezaki T, Yoshizumi T, Uchiyama H, Soejima Y, Ikegami T, Yamashita Y, Kawanaka H, Ikeda T, Saeki H, Morita M, Maehara Y.

Fukuoka Igaku Zasshi. 2013 Dec;104(12):499-506.

PMID:
24693677
12.

Prognostic criteria in colorectal carcinoma constructed by the combination of tumor-related and host-related factors.

Nozoe T, Matono R, Ijichi H, Ohga T, Ezaki T.

Am J Surg. 2014 Jul;208(1):119-23. doi: 10.1016/j.amjsurg.2013.08.043. Epub 2014 Jan 3.

PMID:
24612685
13.

Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.

Nakanoko T, Saeki H, Morita M, Nakashima Y, Ando K, Oki E, Ohga T, Kakeji Y, Toh Y, Maehara Y.

Ann Surg Oncol. 2014 Feb;21(2):597-604. doi: 10.1245/s10434-013-3220-2. Epub 2013 Sep 25. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4;S776.

14.

Non-cirrhotic portal-systemic encephalopathy caused by enlargement of a splenorenal shunt after pancreaticoduodenectomy for locally advanced duodenal cancer: report of a case.

Kasagi Y, Saeki H, Akahoshi T, Kawasaki J, Ando K, Oki E, Ohga T, Tomikawa M, Kakeji Y, Shirabe K, Maehara Y.

Surg Today. 2014 Aug;44(8):1573-6. doi: 10.1007/s00595-013-0679-1. Epub 2013 Aug 28.

15.

[Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer].

Nozoe T, Nozoe E, Iguchi T, Ito S, Ohga T, Koga T, Ezaki T.

Gan To Kagaku Ryoho. 2013 Jul;40(7):907-8. Japanese.

PMID:
23863733
16.

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease.

Tokushige K, Hashimoto E, Kodama K, Tobari M, Matsushita N, Kogiso T, Taniai M, Torii N, Shiratori K, Nishizaki Y, Ohga T, Ohashi Y, Sato T.

J Gastroenterol. 2013 Dec;48(12):1392-400. doi: 10.1007/s00535-013-0766-5. Epub 2013 Mar 13.

17.

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.

Nakanishi R, Harada J, Tuul M, Zhao Y, Ando K, Saeki H, Oki E, Ohga T, Kitao H, Kakeji Y, Maehara Y.

Int J Clin Oncol. 2013 Dec;18(6):1042-8. doi: 10.1007/s10147-012-0501-x. Epub 2012 Nov 29.

PMID:
23188063
18.

Progression from laparoscopic-assisted to totally laparoscopic distal gastrectomy: comparison of circular stapler (i-DST) and linear stapler (BBT) for intracorporeal anastomosis.

Ikeda T, Kawano H, Hisamatsu Y, Ando K, Saeki H, Oki E, Ohga T, Kakeji Y, Tsujitani S, Kohnoe S, Maehara Y.

Surg Endosc. 2013 Jan;27(1):325-32. doi: 10.1007/s00464-012-2433-y. Epub 2012 Jun 26.

19.

Esophageal replacement by colon interposition with microvascular surgery for patients with thoracic esophageal cancer: the utility of superdrainage.

Saeki H, Morita M, Harada N, Egashira A, Oki E, Uchiyama H, Ohga T, Kakeji Y, Sakaguchi Y, Maehara Y.

Dis Esophagus. 2013 Jan;26(1):50-6. doi: 10.1111/j.1442-2050.2012.01327.x. Epub 2012 Mar 6.

PMID:
22394201
20.

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: a Japanese experience.

Baba H, Hayashi N, Emi Y, Kakeji Y, Egashira A, Oki E, Shirabe K, Toyama T, Ohga T, Yamamoto M, Hasegawa H, Kohakura F, Higashi H, Niwa K, Fujita F, Ogata Y, Kohnoe S, Inomata M, Samura H, Tokunaga S, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Surg Today. 2011 Dec;41(12):1610-6. doi: 10.1007/s00595-011-4589-9. Epub 2011 Oct 4.

PMID:
21969193
21.

Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.

Saeki H, Morita M, Nakashima Y, Sonoda H, Hashimoto K, Egashira A, Oki E, Ohga T, Kakeji Y, Maehara Y.

Anticancer Res. 2011 Sep;31(9):3073-7.

PMID:
21868562
22.

Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy.

Morita M, Kumashiro R, Hisamatsu Y, Nakanishi R, Egashira A, Saeki H, Oki E, Ohga T, Kakeji Y, Tsujitani S, Yamanaka T, Maehara Y.

J Gastroenterol. 2011 Nov;46(11):1284-91. doi: 10.1007/s00535-011-0448-0. Epub 2011 Aug 5.

PMID:
21818602
23.

Two-stage operation for high-risk patients with thoracic esophageal cancer: an old operation revisited.

Morita M, Nakanoko T, Kubo N, Fujinaka Y, Ikeda K, Egashira A, Saeki H, Uchiyama H, Ohga T, Kakeji Y, Shirabe K, Ikeda T, Tsujitani S, Maehara Y.

Ann Surg Oncol. 2011 Sep;18(9):2613-21. doi: 10.1245/s10434-011-1654-y. Epub 2011 Mar 16.

PMID:
21409486
24.

Results of surgical treatment for patients with small cell lung cancer.

Hanagiri T, Sugio K, Baba T, Ichiki Y, Yasuda M, Uramoto H, Ohga T, Takenoyama M, Yasumoto K.

J Thorac Oncol. 2009 Aug;4(8):964-8. doi: 10.1097/JTO.0b013e3181a8cd84.

25.

Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer.

Ikeda O, Sakaguchi Y, Aoki Y, Harimoto N, Taomoto J, Masuda T, Ohga T, Adachi E, Toh Y, Okamura T, Baba H.

Surg Endosc. 2009 Oct;23(10):2374-9. doi: 10.1007/s00464-009-0360-3. Epub 2009 Mar 5.

PMID:
19263143
26.

Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v).

Masuda TA, Sakaguchi Y, Toh Y, Aoki Y, Harimoto N, Taomoto J, Ikeda O, Ohga T, Adachi E, Okamura T.

Dig Surg. 2008;25(5):351-8. doi: 10.1159/000165382. Epub 2008 Oct 28.

PMID:
18957850
27.

Multiple and metachronous esophageal intramural metastases from a gastric adenocarcinoma.

Ikeda O, Toh Y, Aoki Y, Harimoto N, Taomoto J, Masuda T, Ohga T, Adachi E, Sakaguchi Y, Okamura T, Hirahashi M, Nishiyama K, Baba H.

Gastric Cancer. 2008;11(2):119-22. doi: 10.1007/s10120-007-0449-0. Epub 2008 Jul 2.

PMID:
18595019
28.

New technique for the retraction of the liver in laparoscopic gastrectomy.

Sakaguchi Y, Ikeda O, Toh Y, Aoki Y, Harimoto N, Taomoto J, Masuda T, Ohga T, Adachi E, Okamura T.

Surg Endosc. 2008 Nov;22(11):2532-4. doi: 10.1007/s00464-008-9801-7. Epub 2008 Mar 5.

PMID:
18320277
29.

Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus.

Ishida M, Morita M, Saeki H, Ohga T, Sadanaga N, Watanabe M, Kakeji Y, Maehara Y.

Anticancer Res. 2007 Sep-Oct;27(5B):3501-6.

30.

Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.

Ito S, Ohga T, Saeki H, Watanabe M, Kakeji Y, Morita M, Yamada T, Maehara Y.

Anticancer Res. 2007 Sep-Oct;27(5A):3345-53.

31.

Overt lymph node metastases from a gastrointestinal stromal tumor of the esophagus.

Masuda T, Toh Y, Kabashima A, Aoki Y, Harimoto N, Ito S, Taomoto J, Ikeda O, Ohga T, Adachi E, Sakaguchi Y, Hirahashi M, Nishiyama K, Okamura T.

J Thorac Cardiovasc Surg. 2007 Sep;134(3):810-1. No abstract available.

32.

Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas.

Toh Y, Ohga T, Itoh S, Kabashima A, Yamamoto K, Adachi E, Sakaguchi Y, Okamura T, Hirata H.

Anticancer Res. 2006 May-Jun;26(3B):2487-91.

33.

Laparoscopy-assisted right hepatic lobectomy using a wall-lifting procedure.

Eguchi D, Nishizaki T, Ohta M, Ishizaki Y, Hanaki N, Okita K, Ohga T, Takahashi I, Ojima Y, Wada H, Tsutsui S.

Surg Endosc. 2006 Aug;20(8):1326-8. Epub 2006 Jun 8.

PMID:
16763923
34.

Production of dihydroxy C50-carotenoid by Aureobacterium sp. FERM P-18698.

Fukuoka S, Ajiki Y, Ohga T, Kawanami Y, Izumori K.

Biosci Biotechnol Biochem. 2004 Dec;68(12):2646-8.

35.

p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.

Ito S, Ohga T, Saeki H, Nakamura T, Watanabe M, Tanaka S, Kakeji Y, Maehara Y.

Int J Cancer. 2005 Jan 1;113(1):22-8.

36.

Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas.

Toh Y, Ohga T, Endo K, Adachi E, Kusumoto H, Haraguchi M, Okamura T, Nicolson GL.

Int J Cancer. 2004 Jun 20;110(3):362-7.

37.

Solitary splenic metastasis derived from esophageal cancer.

Kimura Y, Miyazaki M, Saeki H, Ohga T, Nozoe T, Sugimachi K.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1336-7.

PMID:
14571731
38.

Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.

Kimura Y, Watanabe M, Ohga T, Saeki H, Kakeji Y, Baba H, Maehara Y.

Oncol Rep. 2003 Nov-Dec;10(6):1747-51.

PMID:
14534690
39.
40.

[Evaluation of multi-modality treatment for the patients with advanced esophageal cancer].

Saeki H, Ohga T, Ito S, Futatsugi M, Kimura Y, Kakeji Y, Maehara Y, Nakamura K, Shioyama Y.

Fukuoka Igaku Zasshi. 2002 Dec;93(12):259-65. Japanese.

PMID:
12632630
41.

Role of dihydropyrimidine dehydrogenase activity in patients with esophageal cancer.

Saeki H, Ito S, Futatsugi M, Kimura Y, Ohga T, Sugimachi K.

Anticancer Res. 2002 Nov-Dec;22(6B):3789-92.

PMID:
12552994
42.

Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.

Saeki H, Tanaka S, Sugimachi K, Kimura Y, Miyazaki M, Ohga T, Sugimachi K.

Dig Dis Sci. 2002 Dec;47(12):2738-42.

PMID:
12498294
43.

Cyclin A expression in superficial squamous cell carcinoma of the esophagus and coexisting infiltrated lymphocyte follicle.

Nozoe T, Korenaga D, Futatsugi M, Saeki H, Ohga T, Sugimachi K.

Cancer Lett. 2002 Dec 15;188(1-2):221-9.

PMID:
12406568
44.

Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence.

Nozoe T, Saeki H, Ohga T, Sugimachi K.

Dis Esophagus. 2002;15(2):145-8.

PMID:
12220422
45.

Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma.

Tanaka S, Sugimachi K, Yamashita Yi Y, Ohga T, Shirabe K, Shimada M, Wands JR, Sugimachi K.

Hepatology. 2002 Apr;35(4):861-7.

PMID:
11915032
46.

Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.

Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K.

Clin Cancer Res. 2002 Mar;8(3):817-22.

47.

Clinicopathologic characteristics of superficial spreading type squamous cell carcinoma of the esophagus.

Nozoe T, Saeki H, Ohga T, Sugimachi K.

Oncol Rep. 2002 Mar-Apr;9(2):313-6.

PMID:
11836598
48.

Preoperative hyperthermochemoradiotherapy for esophageal carcinoma.

Nozoe T, Saeki H, Ito S, Ohga T, Kitamura K.

Surgery. 2002 Jan;131(1 Suppl):S35-8. Review.

PMID:
11821785
49.

Surgical and oncological advances in the treatment of esophageal cancer.

Ohga T, Kimura Y, Futatsugi M, Miyazaki M, Saeki H, Nozoe T.

Surgery. 2002 Jan;131(1 Suppl):S28-34.

PMID:
11821784
50.

Biologic and clinical significance of squamous epithelial dysplasia of the esophagus.

Saeki H, Kimura Y, Ito S, Miyazaki M, Ohga T.

Surgery. 2002 Jan;131(1 Suppl):S22-7. Review.

PMID:
11821783

Supplemental Content

Support Center